Alice Q. Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alice Q. Liu has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Eitan Prisman
Division of Otolaryngology, Department of Surgery, Faculty of Medicine University of British Columbia Vancouver British Columbia Canada
3 shared publications Amanda Hu
Division of Otolaryngology-Head and Neck Surgery, University of British Columbia, Vancouver, BC, Canada
2 shared publicationsCarol Lau
Sound idEARS Hearing Clinic, Vancouver, Canada
2 shared publicationsDonald W. Anderson
Division of Otolaryngology-Head and Neck Surgery, Diamond Health Care Centre, University of British Columbia, 2775 Laurel St, 4Th Floor ENT Clinic, V5Z 1M9, Vancouver, BC, Canada
2 shared publicationsEmily C. Deane
Division of Otolaryngology Head & Neck Surgery, University of British Columbia, Vancouver, BC, Canada
2 shared publicationsJ. Scott Durham
Division of Otolaryngology Head & Neck Surgery, University of British Columbia, Vancouver, BC, Canada
2 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Elsevier in Oral Oncology
- Vol. 176, 107957
Avoiding prophylactic tracheostomies in head and neck surgeries with reconstructive free flaps: An institutional shift in practice
- 27 March 2026
- Published by Elsevier in Oral Oncology
- Vol. 176, 107957
Open AccessAvoiding prophylactic tracheostomies in head and neck surgeries with reconstructive free flaps: An institutional shift in practice
- 11 November 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (1) , 538-544
Longus Colli Calcific Tendinitis: A Systematic Review on Current Trends in Management and Treatment
- 11 November 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (1) , 538-544
Longus Colli Calcific Tendinitis: A Systematic Review on Current Trends in Management and Treatment
- Open Access
- 23 September 2024
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (2) , 596-605
Time‐Driven Activity Based Costing of an Annual Canadian Cochlear Implant Program
Objective: To define the cost necessary to run an adult cochlear implant (CI) program, including assessment, subsequent implantation, and follow from the Canadian provincial government perspective.Study Design: Time‐driven activity based costing (TDABC) of a CI program.Setting: Adult provincial CI referral center.Methods: Clinical scenario pathways were developed and verified with stakeholders. TDABC was then applied to all steps involved in the pathway. Costing was based on all patients referred to the CI program in 2019. All costs were calculated in Canadian (and American) dollars as of 2023.Results: This is the first TDABC model of a CI program to the authors knowledge. In 2019, 296 referrals were placed to our CI program and 154 were surgical candidates. The calculated total annual cost for patients referred in 2019 was $4.542 million ($3.365 million USD), or $29,511 ($21,865 USD) per patient implanted. The largest cost contributors to patient cycles were surgical day costs ($23,164 [$17,185 USD] for unilateral, $43,356 [$32,165 USD] for bilateral), switch‐on day costs ($1068 [$791 USD] for unilateral, $1511 [$1120 USD] for bilateral), and audiological assessment costs ($692 [$512 USD]). The highest single cost on the pathway was due to the actual CI device when used. Across other patient steps, the highest costs were related to labor.Conclusion: This TDABC evaluation of a CI program found the annual cost required to meet all referrals was $4.542 million ($3.365 million USD), or $29,511 ($21,865 USD) per patient implanted. The highest single‐cost was associated with the CI device itself.
- 23 September 2024
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (2) , 596-605
Open AccessTime‐Driven Activity Based Costing of an Annual Canadian Cochlear Implant Program
Objective: To define the cost necessary to run an adult cochlear implant (CI) program, including assessment, subsequent implantation, and follow from the Canadian provincial government perspective.Study Design: Time‐driven activity based costing (TDABC) of a CI program.Setting: Adult provincial CI referral center.Methods: Clinical scenario pathways were developed and verified with stakeholders. TDABC was then applied to all steps involved in the pathway. Costing was based on all patients referred to the CI program in 2019. All costs were calculated in Canadian (and American) dollars as of 2023.Results: This is the first TDABC model of a CI program to the authors knowledge. In 2019, 296 referrals were placed to our CI program and 154 were surgical candidates. The calculated total annual cost for patients referred in 2019 was $4.542 million ($3.365 million USD), or $29,511 ($21,865 USD) per patient implanted. The largest cost contributors to patient cycles were surgical day costs ($23,164 [$17,185 USD] for unilateral, $43,356 [$32,165 USD] for bilateral), switch‐on day costs ($1068 [$791 USD] for unilateral, $1511 [$1120 USD] for bilateral), and audiological assessment costs ($692 [$512 USD]). The highest single cost on the pathway was due to the actual CI device when used. Across other patient steps, the highest costs were related to labor.Conclusion: This TDABC evaluation of a CI program found the annual cost required to meet all referrals was $4.542 million ($3.365 million USD), or $29,511 ($21,865 USD) per patient implanted. The highest single‐cost was associated with the CI device itself.
- Open Access
- 10 November 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (6) , 2562-2567
Patient‐Reported Decisional Regret After Operative Otolaryngology Procedures: A Scoping Review
Objective: To review the published literature on decisional regret in adult patients undergoing operative otolaryngology procedures. The primary outcome was decisional regret scale (DRS) scores. DRS scores of 0 indicate no regret, 1–25 mild regret, and >25 moderate to strong/severe regret. Data Sources: A comprehensive librarian‐designed strategy was used to search MEDLINE, Embase, and CINAHL from inception to September 2023. Review Methods: Inclusion criteria consisted of English‐language studies of adult patients who underwent operative otolaryngology treatments and reported DRS scores. Data was extracted by two independent reviewers. Preferred Reporting Items for Systematic Reviews and Meta‐analyses Extension for Scoping Reviews (PRISMA‐ScR) guidelines were followed. Oxford Centre's Levels of Evidence were used for quality assessment. Results: In total, 6306 studies were screened by two independent reviewers; 13 studies were included after full‐text analysis. Subspecialties comprised: Head and neck (10), endocrine (1), general (1), and rhinology (1). The DRS results of the included studies spanned a mean range of 10.1–23.9 or a median range of 0–20.0. There was a trend toward more decisional regret after large head and neck procedures or when patients underwent multiple treatment modalities. Depression, anxiety, and patient‐reported quality of life measures were all correlated with decisional regret. Oxford Centre's Levels of Evidence ranged from 2 to 4. Conclusion: This is the first comprehensive review of decisional regret in otolaryngology. The majority of patients had no or mild (DRS Laryngoscope , 134:2562–2567, 2024
- 10 November 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (6) , 2562-2567
Open AccessPatient‐Reported Decisional Regret After Operative Otolaryngology Procedures: A Scoping Review
Objective: To review the published literature on decisional regret in adult patients undergoing operative otolaryngology procedures. The primary outcome was decisional regret scale (DRS) scores. DRS scores of 0 indicate no regret, 1–25 mild regret, and >25 moderate to strong/severe regret. Data Sources: A comprehensive librarian‐designed strategy was used to search MEDLINE, Embase, and CINAHL from inception to September 2023. Review Methods: Inclusion criteria consisted of English‐language studies of adult patients who underwent operative otolaryngology treatments and reported DRS scores. Data was extracted by two independent reviewers. Preferred Reporting Items for Systematic Reviews and Meta‐analyses Extension for Scoping Reviews (PRISMA‐ScR) guidelines were followed. Oxford Centre's Levels of Evidence were used for quality assessment. Results: In total, 6306 studies were screened by two independent reviewers; 13 studies were included after full‐text analysis. Subspecialties comprised: Head and neck (10), endocrine (1), general (1), and rhinology (1). The DRS results of the included studies spanned a mean range of 10.1–23.9 or a median range of 0–20.0. There was a trend toward more decisional regret after large head and neck procedures or when patients underwent multiple treatment modalities. Depression, anxiety, and patient‐reported quality of life measures were all correlated with decisional regret. Oxford Centre's Levels of Evidence ranged from 2 to 4. Conclusion: This is the first comprehensive review of decisional regret in otolaryngology. The majority of patients had no or mild (DRS Laryngoscope , 134:2562–2567, 2024
- Open Access
- 15 June 2023
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 22
Exploring barriers to sickle cell disease care in a lower-middle income country – A qualitative exploration of the Tharu perspective in rural Nepal
- 15 June 2023
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 22
Open AccessExploring barriers to sickle cell disease care in a lower-middle income country – A qualitative exploration of the Tharu perspective in rural Nepal
- Open Access
- 22 May 2023
- Published by Springer Nature in Trials
- Vol. 24 (1) , 1-10
A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial
Background: Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rates are perpetually low. Motivational interviewing (MI) is a patient-centered counseling aimed at addressing the desire in the patient to change their behavior. The aim of this study is to investigate the impact of one-on-one MI sessions on hearing aid use among new adult users. Methods: A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post-tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be randomly assigned to a treatment or control group. The treatment group will attend a one-on-one MI session hosted by a practicing MI therapist in addition to standard in-person audiological care. The control group will receive standard in-person audiological care. Data is collected at baseline and at 1, 3, 6, and 12 months’ follow-ups. The primary outcomes are data-logged hearing aid use hours and patient-reported outcomes as measured by the International Outcome Inventory for Hearing Aids questionnaire. Associations between intervention and hearing aid use hours and self-reported outcome measures will be assessed. Discussion: This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short and long terms. Results will contribute to the evidence on whether MI counseling has an effect on hearing aid use and may guide future clinical practices. Trial registration: ClinicalTrials.gov NCT04673565. Registered on 17 December 2020.
- 22 May 2023
- Published by Springer Nature in Trials
- Vol. 24 (1) , 1-10
Open AccessA randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial
Background: Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rates are perpetually low. Motivational interviewing (MI) is a patient-centered counseling aimed at addressing the desire in the patient to change their behavior. The aim of this study is to investigate the impact of one-on-one MI sessions on hearing aid use among new adult users. Methods: A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post-tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be randomly assigned to a treatment or control group. The treatment group will attend a one-on-one MI session hosted by a practicing MI therapist in addition to standard in-person audiological care. The control group will receive standard in-person audiological care. Data is collected at baseline and at 1, 3, 6, and 12 months’ follow-ups. The primary outcomes are data-logged hearing aid use hours and patient-reported outcomes as measured by the International Outcome Inventory for Hearing Aids questionnaire. Associations between intervention and hearing aid use hours and self-reported outcome measures will be assessed. Discussion: This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short and long terms. Results will contribute to the evidence on whether MI counseling has an effect on hearing aid use and may guide future clinical practices. Trial registration: ClinicalTrials.gov NCT04673565. Registered on 17 December 2020.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 52 (1) , 1
Correction: The timing of drain removal in parotidectomies: Outcomes of removal at 4 h post-operatively and a Canadian survey of practice patterns
- 1 January 2023
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 52 (1) , 1
Open AccessCorrection: The timing of drain removal in parotidectomies: Outcomes of removal at 4 h post-operatively and a Canadian survey of practice patterns
- Open Access
- 1 January 2023
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 52 (1) , 1-10
The timing of drain removal in parotidectomies: Outcomes of removal at 4 h post-operatively and a Canadian survey of practice patterns
Background: The post-operative management of parotidectomies is highly provider dependent. No guidelines are currently available for timing of parotid drain removal. This study aimed to assess: (1) outcomes and complications after early drain removal (< 4 h, post-operative day [POD] 0) versus late drain removal (POD ≥ 1); (2) current Canadian provider practices. Methods: A single surgeons ten-year parotidectomy practice was reviewed, spanning his practice change from routine POD ≥ 1 drain removal to POD 0 removal, with extraction of patient demographic, disease, and complication variables. An anonymous, cross-sectional survey on parotid drain practices was distributed to Canadian Society of Otolaryngology-Head and Neck Surgery members. Descriptive statistics, Wilcoxon Rank Sum, and unpaired student's t-tests were calculated. Results: In total, 526 patients were included and 44.7% (235/526) had drains removed POD 0. There was no significant difference in hematoma or seroma rates between the POD 0 and POD ≥ 1 drain removal cohorts. The national survey on parotid drain management had 176 responses. The majority (67.9%) reported routinely using drains after parotidectomy and 62.8% reported using a drain output based criteria for removal. The most common cut-off output was 30 ml in 24 h (range 5–70 ml). Conclusion: There was no difference in hematoma or seroma rates for patients with parotid drains removed on POD 0 versus POD ≥ 1. Our national survey found significant variation in Canadian parotidectomy drain removal practices, which may be an area that can be further assessed to minimize hospital resources and improve patient care. Graphic
- 1 January 2023
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 52 (1) , 1-10
Open AccessThe timing of drain removal in parotidectomies: Outcomes of removal at 4 h post-operatively and a Canadian survey of practice patterns
Background: The post-operative management of parotidectomies is highly provider dependent. No guidelines are currently available for timing of parotid drain removal. This study aimed to assess: (1) outcomes and complications after early drain removal (< 4 h, post-operative day [POD] 0) versus late drain removal (POD ≥ 1); (2) current Canadian provider practices. Methods: A single surgeons ten-year parotidectomy practice was reviewed, spanning his practice change from routine POD ≥ 1 drain removal to POD 0 removal, with extraction of patient demographic, disease, and complication variables. An anonymous, cross-sectional survey on parotid drain practices was distributed to Canadian Society of Otolaryngology-Head and Neck Surgery members. Descriptive statistics, Wilcoxon Rank Sum, and unpaired student's t-tests were calculated. Results: In total, 526 patients were included and 44.7% (235/526) had drains removed POD 0. There was no significant difference in hematoma or seroma rates between the POD 0 and POD ≥ 1 drain removal cohorts. The national survey on parotid drain management had 176 responses. The majority (67.9%) reported routinely using drains after parotidectomy and 62.8% reported using a drain output based criteria for removal. The most common cut-off output was 30 ml in 24 h (range 5–70 ml). Conclusion: There was no difference in hematoma or seroma rates for patients with parotid drains removed on POD 0 versus POD ≥ 1. Our national survey found significant variation in Canadian parotidectomy drain removal practices, which may be an area that can be further assessed to minimize hospital resources and improve patient care. Graphic
- Open Access
- 1 January 2023
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 52 (1) , 1-11
Do patients regret having in-office vocal fold injections for glottic insufficiency?
Background: In-office vocal fold injections (VFI) are an effective treatment for glottic insufficiency. The primary objective of this study was to assess if patients reported decisional regret after VFI. Secondary objectives included determining if variables were associated with lower decisional regret. Methods: Case–control study of patients who underwent in-office VFIs for glottic insufficiency from August 2017 to December 2019 at a tertiary laryngology clinic. Participants completed the validated Decision Regret Scale (DRS). Demographic data, clinician's perceptual analysis with GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain), and patient's self-reported Voice Handicap Index-10 (VHI-10) were analyzed. Nonparametric tests as well as univariate and multiple logistics regression were performed. Results: Of patients eligible, 75% (136/182) completed the DRS (mean age 65.4 years (SD 13.9), 58.1% male). Eighty-three (61.0%) reported no decisional regret, thirty-three (24.3%) reported mild decisional regret, and twenty (14.7%) reported moderate to strong decisional regret. Improvement in most recent VHI-10 (Kendall correlation coefficient tau = 0.156, p = 0.029), Grade of voice (tau = 0.236, p value = 0.002) and Breathiness of voice (tau = 0.150, p = 0.044) were associated with lower DRS. Multivariate logistics regression results showed that the change in Grade of voice (OR 9.9, p < 0.01), Roughness (OR 0.2, p < 0.01) and Breathiness (OR 0.2, p < 0.03) were significantly associated with DRS. Conclusion: The majority of patients had no or mild decisional regret after in-office VFI for glottic insufficiency. Both patients who reported less vocal handicap after VFI and clinician-noted improvements in perceptual evaluation of voice after VFI were associated with significantly lower decisional regret. Graphical
- 1 January 2023
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 52 (1) , 1-11
Open AccessDo patients regret having in-office vocal fold injections for glottic insufficiency?
Background: In-office vocal fold injections (VFI) are an effective treatment for glottic insufficiency. The primary objective of this study was to assess if patients reported decisional regret after VFI. Secondary objectives included determining if variables were associated with lower decisional regret. Methods: Case–control study of patients who underwent in-office VFIs for glottic insufficiency from August 2017 to December 2019 at a tertiary laryngology clinic. Participants completed the validated Decision Regret Scale (DRS). Demographic data, clinician's perceptual analysis with GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain), and patient's self-reported Voice Handicap Index-10 (VHI-10) were analyzed. Nonparametric tests as well as univariate and multiple logistics regression were performed. Results: Of patients eligible, 75% (136/182) completed the DRS (mean age 65.4 years (SD 13.9), 58.1% male). Eighty-three (61.0%) reported no decisional regret, thirty-three (24.3%) reported mild decisional regret, and twenty (14.7%) reported moderate to strong decisional regret. Improvement in most recent VHI-10 (Kendall correlation coefficient tau = 0.156, p = 0.029), Grade of voice (tau = 0.236, p value = 0.002) and Breathiness of voice (tau = 0.150, p = 0.044) were associated with lower DRS. Multivariate logistics regression results showed that the change in Grade of voice (OR 9.9, p < 0.01), Roughness (OR 0.2, p < 0.01) and Breathiness (OR 0.2, p < 0.03) were significantly associated with DRS. Conclusion: The majority of patients had no or mild decisional regret after in-office VFI for glottic insufficiency. Both patients who reported less vocal handicap after VFI and clinician-noted improvements in perceptual evaluation of voice after VFI were associated with significantly lower decisional regret. Graphical